PR

Pallipuram Ranganathan Sreeram

Director Director DIN 01678746
DIN 01678746 First appointment Oct 2003 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2003
Shareholding value β€’β€’β€’β€’ Premium profile

About Pallipuram Ranganathan Sreeram

Data last updated:

Pallipuram Ranganathan Sreeram was a Director at Rhine Biogenics Private Limited (2003–2007) and Director at Peepal Builders And Developers Private Limited (from 2007). The companies operate in Pharma.

DIN 01678746
Primary Designation Director
Industry Pharma
First Appointment 08 Oct 2003
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rhine Biogenics Private Limited U24232KL2003PTC016519
Director08 Oct 20032003₹53.20 Cr (FY 2025)Active
Director23 Nov 20072007Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Peepal Builders And Developers Private Limited
Rhine Biogenics Private Limited
Premium access

Shareholding and investment profile for Pallipuram Ranganathan Sreeram

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pallipuram Ranganathan Sreeram

Pallipuram Ranganathan Sreeram was first appointed on 08 Oct 2003 as Director at Rhine Biogenics Private Limited. The most recent appointment on record is 23 Nov 2007 at Peepal Builders And Developers Private Limited.

Pallipuram Ranganathan Sreeram held 2 earlier board appointments: Rhine Biogenics Private Limited (Director, 08 Oct 2003 to 28 Dec 2007); Peepal Builders And Developers Private Limited (Director, from 23 Nov 2007).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available